Elevance Health, Inc.

ELV Healthcare Healthcare Plans

Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 1.40%, EPS fell 13.1%, free cash flow fell 9.01% and total debt rose 4.08%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

428.26 0.17 −0.04%
Market cap
$92.9B
P/E
19.0×
Fwd P/E
20.3×
Dividend yield
1.60%
F-score
6/9
Altman Z
3.09
Beneish M
−2.26
Dividend safety
96/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

12.58% 13.25% 12.10% 11.17%
Piotroski F-Score
5 6 6 6
ROA
4.62% 4.75% 4.27% 4.00%
ROIC
13.32% 12.74% 12.52% 11.83%
Return on Tangible Assets
20.08% 21.25% 19.87% 18.00%
Average Days of Receivables
41.87 39.49 41.51 42.45
Free Cash Flow per Share
16.87 14.17 29.34 28.98
Free Cash Flow
3,767.00 3,174.00 6,450.00 6,289.00
Other line items

Show all line items

Columns are period end dates